Tempest Therapeutics, Inc.

TPST · Nasdaq · SIC 2834: Pharmaceutical Preparations
266
SEC Filings

Business Summary

, Part I, Item 1A. Risk Factors, and Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report. In some cases, you can identify forward-looking statements by the words may, might, will, could, would, should, expect, intend, plan, objective, anticipate, believe, estimate, predict, project, potential, continue and ongoing, or the negative of these terms, or other comparable terminology intended to i...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTPSTdiscussed_in_filing Cybersecurity
topic_mentionTPSTdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-130490EDGAR94K words
2025-03-272024-12-310000950170-25-046144EDGAR—
2024-03-192023-12-310000950170-24-033555EDGAR—
2023-03-222022-12-310000950170-23-009237EDGAR—
2022-03-292021-12-310001628280-22-007717EDGAR—
2021-03-292020-12-310001544227-21-000018EDGAR—
2020-03-112019-12-310001544227-20-000004EDGAR—
2019-04-012018-12-310001558370-19-002660EDGAR—
2018-03-152017-12-310001544227-18-000002EDGAR—
2017-03-022016-12-310001544227-17-000002EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-265946EDGAR54K words
2025-08-112025-06-300000950170-25-106558EDGAR—
2025-05-132025-03-310000950170-25-070441EDGAR—
2024-11-122024-09-300000950170-24-125499EDGAR—
2024-08-082024-06-300000950170-24-094124EDGAR—
2024-05-092024-03-310000950170-24-057072EDGAR—
2023-11-082023-09-300000950170-23-061278EDGAR—
2023-08-102023-06-300000950170-23-041429EDGAR—
2023-05-102023-03-310000950170-23-020579EDGAR—
2022-11-082022-09-300001544227-22-000006EDGAR—
2022-08-152022-06-300001628280-22-022788EDGAR—
2022-05-132022-03-310001628280-22-014231EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130480EDGAR2K words
2026-03-230001193125-26-118618EDGAR—
2026-02-250001193125-26-068614EDGAR—
2026-02-110001193125-26-045543EDGAR—
2026-02-060001193125-26-041190EDGAR—
2026-01-280001193125-26-027203EDGAR—
2026-01-090001193125-26-008938EDGAR—
2025-11-260001193125-25-298604EDGAR—
2025-11-190001193125-25-287163EDGAR—
2025-11-050001193125-25-265937EDGAR—

266 total filings indexed. 234 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001544227
TickerTPST
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f4a5424eefe5f6395bbe0e40bd0dc5d11398b778754180c07f680cf9f1639841
parent: bb253993a934dc7f6fbc97bbe22e5e950457552a40234e2e6f968da30d2ae3d1
content hash: 20e539c9908d77882f7ab6259c12c395d5b1846994523dbdd347d92c6d888a70
signed: 2026-04-13T04:47:51.623Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf